Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
11.53
-0.24 (-2.04%)
At close: Oct 17, 2025, 4:00 PM EDT
11.54
+0.01 (0.09%)
After-hours: Oct 17, 2025, 4:10 PM EDT
Exagen Stock Forecast
Stock Price Forecast
The 5 analysts that cover Exagen stock have a consensus rating of "Strong Buy" and an average price target of $12, which forecasts a 4.08% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $15.
Price Target: $12 (+4.08%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exagen stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Maintains $12 → $15 | Buy | Maintains | $12 → $15 | +30.10% | Oct 14, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +30.10% | Sep 11, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | -4.60% | Jul 30, 2025 |
| Keybanc | Keybanc | Hold → Buy Upgrades $17 | Hold → Buy | Upgrades | $17 | +47.44% | Jul 30, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +4.08% | Jul 23, 2025 |
Financial Forecast
Revenue This Year
68.04M
from 55.64M
Increased by 22.28%
Revenue Next Year
77.58M
from 68.04M
Increased by 14.03%
EPS This Year
-0.68
from -0.83
EPS Next Year
-0.35
from -0.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 71.9M | 83.6M | |||
| Avg | 68.0M | 77.6M | |||
| Low | 65.2M | 74.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 29.3% | 22.8% | |||
| Avg | 22.3% | 14.0% | |||
| Low | 17.1% | 8.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.57 | -0.09 | |||
| Avg | -0.68 | -0.35 | |||
| Low | -0.78 | -0.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.